A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules

Yanli Lin, Qixin Leng, Zhengran Jiang, Maria A. Guarnera, Yun Zhou, Xueqi Chen, Heping Wang, Wenxian Zhou, Ling Cai, Hong Bin Fang, Jie Li, Hairong Jin, Linghui Wang, Shaoqiong Yi, Wei Lu, David Evers, Carol B. Fowle, Yun Su, Feng Jiang

Research output: Contribution to journalArticle

Abstract

Lung cancer is primarily caused by cigarette smoking and the leading cancer killer in the USA and across the world. Early detection of lung cancer by low-dose CT (LDCT) can reduce the mortality. However, LDCT dramatically increases the number of indeterminate pulmonary nodules (PNs), leading to overdiagnosis. Having a definitive preoperative diagnosis of malignant PNs is clinically important. Using microarray and droplet digital PCR to directly profile plasma miRNA expressions of 135 patients with PNs, we identified 11 plasma miRNAs that displayed a significant difference between patients with malignant versus benign PNs. Using multivariate logistic regression analysis of the molecular results and clinical/radiological characteristics, we developed an integrated classifier comprising two miRNA biomarkers and one radiological characteristic for distinguishing malignant from benign PNs. The classifier had 89.9% sensitivity and 90.9% specificity, being significantly higher compared with the biomarkers or clinical/radiological characteristics alone (all p < 0.05). The classifier was validated in two independent sets of patients. We have for the first time shown that the integration of plasma biomarkers and radiological characteristics could more accurately identify lung cancer among indeterminate PNs. Future use of the classifier could spare individuals with benign growths from the harmful diagnostic procedures, while allowing effective treatments to be immediately initiated for lung cancer, thereby reduces the mortality and cost. Nevertheless, further prospective validation of this classifier is warranted.

Original languageEnglish (US)
Pages (from-to)1240-1248
Number of pages9
JournalInternational Journal of Cancer
Volume141
Issue number6
DOIs
StatePublished - Sep 15 2017

Fingerprint

Biomarkers
Lung
Lung Neoplasms
MicroRNAs
Mortality
Early Detection of Cancer
Logistic Models
Smoking
Regression Analysis
Costs and Cost Analysis
Sensitivity and Specificity
Polymerase Chain Reaction
Growth
Neoplasms
Therapeutics

Keywords

  • biomarkers
  • CT
  • lung cancer
  • miRNA
  • pulmonary nodules

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules. / Lin, Yanli; Leng, Qixin; Jiang, Zhengran; Guarnera, Maria A.; Zhou, Yun; Chen, Xueqi; Wang, Heping; Zhou, Wenxian; Cai, Ling; Fang, Hong Bin; Li, Jie; Jin, Hairong; Wang, Linghui; Yi, Shaoqiong; Lu, Wei; Evers, David; Fowle, Carol B.; Su, Yun; Jiang, Feng.

In: International Journal of Cancer, Vol. 141, No. 6, 15.09.2017, p. 1240-1248.

Research output: Contribution to journalArticle

Lin, Y, Leng, Q, Jiang, Z, Guarnera, MA, Zhou, Y, Chen, X, Wang, H, Zhou, W, Cai, L, Fang, HB, Li, J, Jin, H, Wang, L, Yi, S, Lu, W, Evers, D, Fowle, CB, Su, Y & Jiang, F 2017, 'A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules', International Journal of Cancer, vol. 141, no. 6, pp. 1240-1248. https://doi.org/10.1002/ijc.30822
Lin, Yanli ; Leng, Qixin ; Jiang, Zhengran ; Guarnera, Maria A. ; Zhou, Yun ; Chen, Xueqi ; Wang, Heping ; Zhou, Wenxian ; Cai, Ling ; Fang, Hong Bin ; Li, Jie ; Jin, Hairong ; Wang, Linghui ; Yi, Shaoqiong ; Lu, Wei ; Evers, David ; Fowle, Carol B. ; Su, Yun ; Jiang, Feng. / A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules. In: International Journal of Cancer. 2017 ; Vol. 141, No. 6. pp. 1240-1248.
@article{68084cda95e64b9d90f904af5a135646,
title = "A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules",
abstract = "Lung cancer is primarily caused by cigarette smoking and the leading cancer killer in the USA and across the world. Early detection of lung cancer by low-dose CT (LDCT) can reduce the mortality. However, LDCT dramatically increases the number of indeterminate pulmonary nodules (PNs), leading to overdiagnosis. Having a definitive preoperative diagnosis of malignant PNs is clinically important. Using microarray and droplet digital PCR to directly profile plasma miRNA expressions of 135 patients with PNs, we identified 11 plasma miRNAs that displayed a significant difference between patients with malignant versus benign PNs. Using multivariate logistic regression analysis of the molecular results and clinical/radiological characteristics, we developed an integrated classifier comprising two miRNA biomarkers and one radiological characteristic for distinguishing malignant from benign PNs. The classifier had 89.9{\%} sensitivity and 90.9{\%} specificity, being significantly higher compared with the biomarkers or clinical/radiological characteristics alone (all p < 0.05). The classifier was validated in two independent sets of patients. We have for the first time shown that the integration of plasma biomarkers and radiological characteristics could more accurately identify lung cancer among indeterminate PNs. Future use of the classifier could spare individuals with benign growths from the harmful diagnostic procedures, while allowing effective treatments to be immediately initiated for lung cancer, thereby reduces the mortality and cost. Nevertheless, further prospective validation of this classifier is warranted.",
keywords = "biomarkers, CT, lung cancer, miRNA, pulmonary nodules",
author = "Yanli Lin and Qixin Leng and Zhengran Jiang and Guarnera, {Maria A.} and Yun Zhou and Xueqi Chen and Heping Wang and Wenxian Zhou and Ling Cai and Fang, {Hong Bin} and Jie Li and Hairong Jin and Linghui Wang and Shaoqiong Yi and Wei Lu and David Evers and Fowle, {Carol B.} and Yun Su and Feng Jiang",
year = "2017",
month = "9",
day = "15",
doi = "10.1002/ijc.30822",
language = "English (US)",
volume = "141",
pages = "1240--1248",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules

AU - Lin, Yanli

AU - Leng, Qixin

AU - Jiang, Zhengran

AU - Guarnera, Maria A.

AU - Zhou, Yun

AU - Chen, Xueqi

AU - Wang, Heping

AU - Zhou, Wenxian

AU - Cai, Ling

AU - Fang, Hong Bin

AU - Li, Jie

AU - Jin, Hairong

AU - Wang, Linghui

AU - Yi, Shaoqiong

AU - Lu, Wei

AU - Evers, David

AU - Fowle, Carol B.

AU - Su, Yun

AU - Jiang, Feng

PY - 2017/9/15

Y1 - 2017/9/15

N2 - Lung cancer is primarily caused by cigarette smoking and the leading cancer killer in the USA and across the world. Early detection of lung cancer by low-dose CT (LDCT) can reduce the mortality. However, LDCT dramatically increases the number of indeterminate pulmonary nodules (PNs), leading to overdiagnosis. Having a definitive preoperative diagnosis of malignant PNs is clinically important. Using microarray and droplet digital PCR to directly profile plasma miRNA expressions of 135 patients with PNs, we identified 11 plasma miRNAs that displayed a significant difference between patients with malignant versus benign PNs. Using multivariate logistic regression analysis of the molecular results and clinical/radiological characteristics, we developed an integrated classifier comprising two miRNA biomarkers and one radiological characteristic for distinguishing malignant from benign PNs. The classifier had 89.9% sensitivity and 90.9% specificity, being significantly higher compared with the biomarkers or clinical/radiological characteristics alone (all p < 0.05). The classifier was validated in two independent sets of patients. We have for the first time shown that the integration of plasma biomarkers and radiological characteristics could more accurately identify lung cancer among indeterminate PNs. Future use of the classifier could spare individuals with benign growths from the harmful diagnostic procedures, while allowing effective treatments to be immediately initiated for lung cancer, thereby reduces the mortality and cost. Nevertheless, further prospective validation of this classifier is warranted.

AB - Lung cancer is primarily caused by cigarette smoking and the leading cancer killer in the USA and across the world. Early detection of lung cancer by low-dose CT (LDCT) can reduce the mortality. However, LDCT dramatically increases the number of indeterminate pulmonary nodules (PNs), leading to overdiagnosis. Having a definitive preoperative diagnosis of malignant PNs is clinically important. Using microarray and droplet digital PCR to directly profile plasma miRNA expressions of 135 patients with PNs, we identified 11 plasma miRNAs that displayed a significant difference between patients with malignant versus benign PNs. Using multivariate logistic regression analysis of the molecular results and clinical/radiological characteristics, we developed an integrated classifier comprising two miRNA biomarkers and one radiological characteristic for distinguishing malignant from benign PNs. The classifier had 89.9% sensitivity and 90.9% specificity, being significantly higher compared with the biomarkers or clinical/radiological characteristics alone (all p < 0.05). The classifier was validated in two independent sets of patients. We have for the first time shown that the integration of plasma biomarkers and radiological characteristics could more accurately identify lung cancer among indeterminate PNs. Future use of the classifier could spare individuals with benign growths from the harmful diagnostic procedures, while allowing effective treatments to be immediately initiated for lung cancer, thereby reduces the mortality and cost. Nevertheless, further prospective validation of this classifier is warranted.

KW - biomarkers

KW - CT

KW - lung cancer

KW - miRNA

KW - pulmonary nodules

UR - http://www.scopus.com/inward/record.url?scp=85021190826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021190826&partnerID=8YFLogxK

U2 - 10.1002/ijc.30822

DO - 10.1002/ijc.30822

M3 - Article

VL - 141

SP - 1240

EP - 1248

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -